NINDS Archives
Protein interactions and brain function
Feb. 20, 2020—Roger Colbran and colleagues have discovered new molecular details about the function of an enzyme with a key role in shaping learning and memory.
Imaging nerve regeneration
Jan. 28, 2020—Diffusion MRI may provide a noninvasive approach to assess nerve regeneration and distinguish successful from unsuccessful repairs earlier.
VIGH’s Trevathan appointed to NINDS Advisory Council
Jan. 23, 2020—Edwin Trevathan, MD, MPH, director of the Vanderbilt Institute for Global Health, has been appointed to the Advisory Council for the National Institute for Neurological Diseases and Stroke (NINDS) of the National Institutes of Health.
A new anti-seizure target?
Dec. 12, 2019—Vanderbilt neurologists have identified a protein modification that could be targeted to reduce neuronal excitability in epilepsy.
Microscopic spines connect worm neurons
Oct. 17, 2019—Worm neurons have microscopic “spines” — where nerve-to-nerve communication happens — that share features with mammalian neurons, supporting the use of worms to study spine genetics and biology.
Astrocytes and epilepsy
Sep. 9, 2019—A protein with important functions in astrocytes — star-shaped brain support cells — may alter neuronal excitability and contribute to seizure activity, Vanderbilt researchers report.
How nerves may lose their insulation
Aug. 22, 2019—Vanderbilt’s Bruce Carter and colleagues have discovered how genetic changes in the protein PMP22 may contribute to a disease of peripheral nerves.
Exploring the brain’s white matter
Mar. 14, 2019—New comprehensive functional MRI measurements point to the need to update models for assessing brain white matter activity and physiology.
Team seeks to create gene expression map of worm’s nervous system
Dec. 6, 2018—How do you build a brain? What “rules” govern where neurons end up, how they connect to each other, and which functions they perform?
Vitamin C protects brain from seizures
Nov. 8, 2018—Brain ascorbate — vitamin C — is important for protecting the brain against seizures and cognitive decline in Alzheimer’s disease.
Probing the pathology of impaired cognition
Oct. 25, 2018—Detecting the neuropathology underlying cognitive impairment by lead to new targeted therapies.
A brain-builder called “Shh”
Aug. 30, 2018—New findings demonstrate a previously unappreciated role of Shh signaling activity in the proliferation of CGNPs — the presumed cell-of-origin for a subset of the malignant pediatric brain tumor medulloblastoma.
